Last 12 months
Inside the activity.
11 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 3 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2021 Filed Sep 14, 2021 21:12 UTC |
Huizinga Robert BindertEVP of Research
|
SaleCommon Stock | 5,000 | $19.83 | $99,150.00 |
DisclosureSEC source: 0001628280-21-018595 · wf-form4_163165391729313.xml · nonDerivative · entry 1 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,592 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 21:11 UTC |
Solomons NeilChief Medical Officer
|
SaleCommon Shares | 150,000 | $19.84 | $2,976,000.00 |
DisclosureSEC source: 0001628280-21-018594 · wf-form4_163165384671882.xml · nonDerivative · entry 2 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,299 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $19.77 to $19.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 20:04 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Stock | 7,500 | $18.10 | $135,750.00 |
DisclosureSEC source: 0001628280-21-018219 · wf-form4_163113146158608.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,861 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2021. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 20:03 UTC |
Huizinga Robert BindertEVP of Research
|
SaleCommon Stock | 5,000 | $18.30 | $91,500.00 |
DisclosureSEC source: 0001628280-21-018218 · wf-form4_163113139756555.xml · nonDerivative · entry 1 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,592 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $18.30 to $18.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:09 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Stock | 22,500 | $17.81 | $400,725.00 |
DisclosureSEC source: 0001628280-21-017720 · wf-form4_163009494191302.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,361 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $17.76 to $17.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 25, 2021 Filed Aug 26, 2021 20:15 UTC |
Solomons NeilChief Medical Officer
|
SaleCommon Stock | 5,000 | $15.85 | $79,250.00 |
DisclosureSEC source: 0001628280-21-017662 · wf-form4_163000892467082.xml · nonDerivative · entry 1 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,299 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2021. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 20:11 UTC |
Solomons NeilChief Medical Officer
|
SaleCommon Stock | 45,000 | $16.03 | $721,350.00 |
DisclosureSEC source: 0001628280-21-016407 · wf-form4_162862630456598.xml · nonDerivative · entry 1 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,299 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2021. F2 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.00 to $16.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 20:09 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Stock | 5,000 | $16.01 | $80,050.00 |
DisclosureSEC source: 0001628280-21-016403 · wf-form4_162862613567685.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,861 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2021. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 28, 2021 Filed Jul 29, 2021 20:09 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Stock | 5,000 | $13.86 | $69,300.00 |
DisclosureSEC source: 0001628280-21-014882 · wf-form4_162758934279152.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,861 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2021. F2 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the sold date. F3 · price: The price in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 20:06 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Stock | 5,000 | $13.76 | $68,800.00 |
DisclosureSEC source: 0001628280-21-012730 · wf-form4_162447875291749.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,861 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2021. F2 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the sold date. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:20 UTC |
MILNE GEORGE M JRDirector
|
GrantStock Option (right to buy) · Derivative | 31,347 | $0.00 Strike: $12.86 | $0.00 |
DisclosureSEC source: 0001628280-21-012386 · wf-form4_162389281306609.xml · derivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 Underlying: Stock Option (right to buy) · 31,347 shares Expires 2031-06-14 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on July 14, 2021. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 21:23 UTC |
Hagan Joseph PDirector
|
GrantStock Option (right to buy) · Derivative | 31,347 | $0.00 Strike: $12.86 | $0.00 |
DisclosureSEC source: 0001628280-21-012389 · wf-form4_162389298391433.xml · derivative · entry 1 Hagan Joseph P · CIK 0001465278 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 Underlying: Common Shares · 31,347 shares Expires 2031-06-14 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on July 14, 2021. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC |
Walbert Timothy PDirector
|
GrantStock Option (right to buy) · Derivative | 31,347 | $0.00 Strike: $12.86 | $0.00 |
DisclosureSEC source: 0001628280-21-012388 · wf-form4_162389292098153.xml · derivative · entry 1 Walbert Timothy P · CIK 0001349376 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 Underlying: Common Shares · 31,347 shares Expires 2031-06-14 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on July 14, 2021. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:21 UTC |
Billen DanielDirector
|
GrantStock Option (right to buy) · Derivative | 31,347 | $0.00 Strike: $12.86 | $0.00 |
DisclosureSEC source: 0001628280-21-012387 · wf-form4_162389285746391.xml · derivative · entry 1 Billen Daniel · CIK 0001837593 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 Underlying: Common Shares · 31,347 shares Expires 2031-06-14 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on July 14, 2021. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:17 UTC |
MacKay-Dunn R. HectorDirector
|
GrantStock Option (right to buy) · Derivative | 31,347 | $0.00 Strike: $12.86 | $0.00 |
DisclosureSEC source: 0001628280-21-012384 · wf-form4_162389264098194.xml · derivative · entry 1 MacKay-Dunn R. Hector · CIK 0001838521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 Underlying: Common Shares · 31,347 shares Expires 2031-06-14 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on July 14, 2021. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:19 UTC |
Jayne David R.W.Director
|
GrantStock Option (right to buy) · Derivative | 31,347 | $0.00 Strike: $12.86 | $0.00 |
DisclosureSEC source: 0001628280-21-012385 · wf-form4_162389275893099.xml · derivative · entry 1 Jayne David R.W. · CIK 0001838242 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 Underlying: Common Shares · 31,347 shares Expires 2031-06-14 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on July 14, 2021. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:16 UTC |
Leversage JillDirector
|
GrantStock Option (right to buy) · Derivative | 31,347 | $0.00 Strike: $12.86 | $0.00 |
DisclosureSEC source: 0001628280-21-012383 · wf-form4_162389253984760.xml · derivative · entry 1 Leversage Jill · CIK 0001837374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,347 Underlying: Common Shares · 31,347 shares Expires 2031-06-14 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on July 14, 2021. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 20:39 UTC |
Balakrishnan BrindaDirector
|
GrantStock Option (right to buy) · Derivative | 53,291 | $0.00 Strike: $12.86 | $0.00 |
DisclosureSEC source: 0001628280-21-012469 · wf-form4_162396231828957.xml · derivative · entry 1 Balakrishnan Brinda · CIK 0001868236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,291 Underlying: Common Shares · 53,291 shares Expires 2031-06-14 F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on July 14, 2021. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:17 UTC |
MacKay-Dunn R. HectorDirector
|
PurchaseCommon Stock | 1,600 | $11.28 | $18,040.00 |
DisclosureSEC source: 0001628280-21-010163 · wf-form4_162093703761728.xml · nonDerivative · entry 4 MacKay-Dunn R. Hector · CIK 0001838521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:17 UTC |
MacKay-Dunn R. HectorDirector
|
PurchaseCommon Stock | 1,400 | $11.26 | $15,764.00 |
DisclosureSEC source: 0001628280-21-010163 · wf-form4_162093703761728.xml · nonDerivative · entry 3 MacKay-Dunn R. Hector · CIK 0001838521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 Read SEC document |
| May 11, 2021 Filed May 11, 2021 21:22 UTC |
Huizinga Robert BindertEx Vice President of Research
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001628280-21-009847 · wf-form4_162076816300353.xml · derivative · entry 2 Huizinga Robert Bindert · CIK 0001837648 · Ex Vice President of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2021-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F2 · derivative.exercise_date: The shares subject to the options are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. The expiration date was extended as a result of the blackout period. Read SEC document |
| May 11, 2021 Filed May 11, 2021 21:22 UTC |
Huizinga Robert BindertEx Vice President of Research
|
Exercise / conversionCommon Stock | 40,000 | $3.02 | $120,800.00 |
DisclosureSEC source: 0001628280-21-009847 · wf-form4_162076816300353.xml · nonDerivative · entry 1 Huizinga Robert Bindert · CIK 0001837648 · Ex Vice President of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| May 11, 2021 Filed May 11, 2021 20:53 UTC |
Miller Joseph MChief Financial Officer
|
PurchaseCommon Stock | 1,000 | $9.74 | $9,740.00 |
DisclosureSEC source: 0001628280-21-009835 · wf-form4_162076642191509.xml · nonDerivative · entry 1 Miller Joseph M · CIK 0001746372 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:32 UTC |
Greenleaf PeterDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,992 | $11.11 | $33,241.12 |
DisclosureSEC source: 0001628280-21-010022 · wf-form4_162085152431857.xml · nonDerivative · entry 2 Greenleaf Peter · CIK 0001363683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,453 F2 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $10.91 to $11.275, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:32 UTC |
Greenleaf PeterDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,133 | $10.15 | $21,649.95 |
DisclosureSEC source: 0001628280-21-010022 · wf-form4_162085152431857.xml · nonDerivative · entry 1 Greenleaf Peter · CIK 0001363683 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,461 F1 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $9.74 to $10.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:34 UTC |
Donley Matthew MaxwellEx VP, Intern'l Operations
|
PurchaseCommon Stock | 9,900 | $10.07 | $99,738.54 |
DisclosureSEC source: 0001628280-21-010023 · wf-form4_162085164781441.xml · nonDerivative · entry 1 Donley Matthew Maxwell · CIK 0001636642 · Ex VP, Intern'l Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:30 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001628280-21-010021 · wf-form4_162085139436066.xml · derivative · entry 2 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2021-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F2 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. The expiration date was extended as a result of the blackout period. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:30 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 20,000 | $3.02 | $60,400.00 |
DisclosureSEC source: 0001628280-21-010021 · wf-form4_162085139436066.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:28 UTC |
Leversage JillDirector
|
PurchaseCommon Stock | 2,500 | $10.96 | $27,389.25 |
DisclosureSEC source: 0001628280-21-010018 · wf-form4_162085127566189.xml · nonDerivative · entry 1 Leversage Jill · CIK 0001837374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,700 Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:17 UTC |
MacKay-Dunn R. HectorDirector
|
PurchaseCommon Stock | 1,000 | $11.14 | $11,140.00 |
DisclosureSEC source: 0001628280-21-010163 · wf-form4_162093703761728.xml · nonDerivative · entry 2 MacKay-Dunn R. Hector · CIK 0001838521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:17 UTC |
MacKay-Dunn R. HectorDirector
|
PurchaseCommon Stock | 500 | $11.17 | $5,585.00 |
DisclosureSEC source: 0001628280-21-010163 · wf-form4_162093703761728.xml · nonDerivative · entry 1 MacKay-Dunn R. Hector · CIK 0001838521 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 20:36 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001628280-21-004740 · wf-form4_161584054793459.xml · derivative · entry 3 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2021-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 20:36 UTC |
Solomons NeilChief Medical Officer
|
SaleCommon Stock | 40,000 | $13.49 | $539,600.00 |
DisclosureSEC source: 0001628280-21-004740 · wf-form4_161584054793459.xml · nonDerivative · entry 2 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,299 F2 · price: The price in column 4 is a weighted average price and were converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the sold date. These shares were sold in multiple transactions ranging from $13.34 to $13.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| March 12, 2021 Filed Mar 15, 2021 20:36 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionCommon Stock | 40,000 | $3.02 | $120,800.00 |
DisclosureSEC source: 0001628280-21-004740 · wf-form4_161584054793459.xml · nonDerivative · entry 1 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:25 UTC |
MILNE GEORGE M JRDirector
|
PurchaseCommon Stock | 5,000 | $13.00 | $65,000.00 |
DisclosureSEC source: 0001628280-21-004265 · wf-form4_161532509442005.xml · nonDerivative · entry 1 MILNE GEORGE M JR · CIK 0001179552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.995 to $13.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 20:18 UTC |
Hayden Michael RDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $6.42 | $0.00 |
DisclosureSEC source: 0001628280-21-001279 · wf-form4_161229708841560.xml · derivative · entry 6 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2029-07-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F2 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 20:18 UTC |
Hayden Michael RDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $6.06 | $0.00 |
DisclosureSEC source: 0001628280-21-001279 · wf-form4_161229708841560.xml · derivative · entry 5 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2029-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F2 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 20:18 UTC |
Hayden Michael RDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $5.44 | $0.00 |
DisclosureSEC source: 0001628280-21-001279 · wf-form4_161229708841560.xml · derivative · entry 4 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2028-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F2 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 20:18 UTC |
Hayden Michael RDirector
|
Exercise / conversionCommon Shares | 15,000 | $6.42 | $96,300.00 |
DisclosureSEC source: 0001628280-21-001279 · wf-form4_161229708841560.xml · nonDerivative · entry 3 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 20:18 UTC |
Hayden Michael RDirector
|
Exercise / conversionCommon Shares | 30,000 | $6.06 | $181,800.00 |
DisclosureSEC source: 0001628280-21-001279 · wf-form4_161229708841560.xml · nonDerivative · entry 2 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 20:18 UTC |
Hayden Michael RDirector
|
Exercise / conversionCommon Shares | 50,000 | $5.44 | $272,000.00 |
DisclosureSEC source: 0001628280-21-001279 · wf-form4_161229708841560.xml · nonDerivative · entry 1 Hayden Michael R · CIK 0001352908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 20:22 UTC |
Leversage JillDirector
|
PurchaseCommon Stock | 1,200 | $16.03 | $19,236.00 |
DisclosureSEC source: 0001628280-21-001281 · wf-form4_161229735118364.xml · nonDerivative · entry 2 Leversage Jill · CIK 0001837374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the purchase date. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 20:22 UTC |
Leversage JillDirector
|
PurchaseCommon Shares | 400 | $16.03 | $6,412.00 |
DisclosureSEC source: 0001628280-21-001281 · wf-form4_161229735118364.xml · nonDerivative · entry 1 Leversage Jill · CIK 0001837374 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 400 F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the purchase date. Read SEC document |
| January 28, 2021 Filed Jan 29, 2021 17:24 UTC |
Robertson Stephen P.EVP, General Counsel
|
PurchaseCommon Stock | 900 | $16.14 | $14,526.00 |
DisclosureSEC source: 0001628280-21-001096 · wf-form4_161194104312841.xml · nonDerivative · entry 1 Robertson Stephen P. · CIK 0001837798 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,720 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.